| Followers | 843 |
| Posts | 122852 |
| Boards Moderated | 8 |
| Alias Born | 09/05/2002 |
Tuesday, January 09, 2024 8:44:46 AM
BNTX’s 2024 clinical and financial goals:
https://finance.yahoo.com/news/biontech-outlines-2024-strategic-priorities-114500463.html
https://finance.yahoo.com/news/biontech-outlines-2024-strategic-priorities-114500463.html
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent BNTX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/02/2026 08:15:44 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 04/01/2026 08:16:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:04:48 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:03:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:01:42 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:00:09 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 09:58:27 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 09:57:30 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 09:55:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/24/2026 09:09:47 PM
- BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer • GlobeNewswire Inc. • 03/24/2026 10:45:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 09:43:08 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 09:41:10 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 09:39:22 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 09:36:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 12:02:48 PM
- BioNTech shares plunge over 19% after fourth-quarter earnings miss • IH Market News • 03/10/2026 12:58:53 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/10/2026 10:55:57 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/10/2026 10:53:33 AM
- BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update • GlobeNewswire Inc. • 03/10/2026 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/10/2026 10:34:31 AM
- BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030 • GlobeNewswire Inc. • 03/10/2026 10:33:07 AM
- Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 • PR Newswire (US) • 02/25/2026 02:00:00 PM
- Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 • PR Newswire (Canada) • 02/25/2026 02:00:00 PM
- BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 • GlobeNewswire Inc. • 02/24/2026 11:45:00 AM
